Cargando…
Immune-Complexome Analysis Identifies Immunoglobulin-Bound Biomarkers That Predict the Response to Chemotherapy of Pancreatic Cancer Patients
Pancreatic Ductal Adenocarcinoma (PDA) is an aggressive malignancy with a very poor outcome. Although chemotherapy (CT) treatment has poor efficacy, it can enhance tumor immunogenicity. Tumor-Associated Antigens (TAA) are self-proteins that are overexpressed in tumors that may induce antibody produc...
Autores principales: | Mandili, Giorgia, Follia, Laura, Ferrero, Giulio, Katayama, Hiroyuki, Hong, Wang, Momin, Amin A., Capello, Michela, Giordano, Daniele, Spadi, Rosella, Satolli, Maria Antonietta, Evangelista, Andrea, Hanash, Samir M., Cordero, Francesca, Novelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140049/ https://www.ncbi.nlm.nih.gov/pubmed/32245227 http://dx.doi.org/10.3390/cancers12030746 |
Ejemplares similares
-
Integrative Analysis of Novel Metabolic Subtypes in Pancreatic Cancer Fosters New Prognostic Biomarkers
por: Follia, Laura, et al.
Publicado: (2019) -
In pancreatic cancer, chemotherapy increases antitumor responses to tumor-associated antigens and potentiates DNA vaccination
por: Mandili, Giorgia, et al.
Publicado: (2020) -
The Mitochondrial Complexome of Medicago truncatula
por: Kiirika, Leonard Muriithi, et al.
Publicado: (2013) -
Complexome Profiling: Assembly and Remodeling of Protein Complexes
por: Wittig, Ilka, et al.
Publicado: (2021) -
Global organization of protein complexome in the yeast Saccharomyces cerevisiae
por: Lee, Sang Hoon, et al.
Publicado: (2011)